Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care
|
October 9, 2013
Lipid droplet metabolism
Victor K Khor, Wen-Jun Shen, Fredric B Kraemer
Endocrinology
|
August 2, 2008
Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse
Victor K Khor, Ming Han Tong, Yueming Qian, et al.
Molecular and Cellular Endocrinology
|
October 24, 2012
Cholesterol ester droplets and steroidogenesis
Fredric B Kraemer, Victor K Khor, Wen-Jun Shen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
August 5, 2010
Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice
Victor K Khor, Ravindra Dhir, Xiaoyan Yin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2011
Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3
Rexford S Ahima, Takara L Stanley, Victor K Khor, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 16, 2016
SNARE-Mediated Cholesterol Movement to Mitochondria Supports Steroidogenesis in Rodent Cells
Ye Lin, Xiaoming Hou, Wen-Jun Shen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2010
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome
Takara L Stanley, Markella V Zanni, Stine Johnsen, et al.
Plos One
|
August 12, 2014
The proteome of cholesteryl-ester-enriched versus triacylglycerol-enriched lipid droplets
Victor K Khor, Robert Ahrends, Ye Lin, et al.
Gynecologic Oncology
|
August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
Sandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
Charles N Landen, Luciana Molinero, Habib Hamidi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Opinion in Clinical Nutrition and Metabolic Care
|
October 9, 2013
Lipid droplet metabolism
Victor K Khor, Wen-Jun Shen, Fredric B Kraemer
Endocrinology
|
August 2, 2008
Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse
Victor K Khor, Ming Han Tong, Yueming Qian, et al.
Molecular and Cellular Endocrinology
|
October 24, 2012
Cholesterol ester droplets and steroidogenesis
Fredric B Kraemer, Victor K Khor, Wen-Jun Shen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
August 5, 2010
Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice
Victor K Khor, Ravindra Dhir, Xiaoyan Yin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2011
Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3
Rexford S Ahima, Takara L Stanley, Victor K Khor, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 16, 2016
SNARE-Mediated Cholesterol Movement to Mitochondria Supports Steroidogenesis in Rodent Cells
Ye Lin, Xiaoming Hou, Wen-Jun Shen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2010
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome
Takara L Stanley, Markella V Zanni, Stine Johnsen, et al.
Plos One
|
August 12, 2014
The proteome of cholesteryl-ester-enriched versus triacylglycerol-enriched lipid droplets
Victor K Khor, Robert Ahrends, Ye Lin, et al.
Gynecologic Oncology
|
August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
Sandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
Charles N Landen, Luciana Molinero, Habib Hamidi, et al.
Page
of 2